Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Cancer Lett. 2013 Jan 23;340(2):10.1016/j.canlet.2012.12.028. doi: 10.1016/j.canlet.2012.12.028

Table 1.

Recent clonal evolution studies using next generation sequencing approaches.

Study Technology Cohort Disease Findings
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. NEJM (2012) WXS, SNP Array, mRNA array 4 metastatic renal-cell carcinoma, pre/post treatment Intratumoral heterogeneity, metastasis, and treatment resistance emerge from distinct subclonal mutations within a single tumor
Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell (2011) SNP Array, FISH 350+206 (TC GA) Glioblastoma (GBM) Divergent subclones evolve from a common ancestor and accumulate independent drivers via mosaic tyrosine kinase amplifications
Inferring tumor progression from genomic heterogeneity. GR (2010) CGH, macro dissection, flow sorting, FISH 20 Breast (primary ductal breast carcinomas) Distinct heterogeneous clones expand from a common ancestor with accumulation of unique copy number and structural aberrations patterns
Tumour evolution inferred by single-cell sequencing. Nature (2011). Single Cell WGS, CNV 2 Breast Cancer Tumor growth is typified by punctuated clonal expansions accompanied by copy number changes that may lead to clonal divergence
Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell (2012) WXS + Single Cell WXS 1 Kidney (Clear cell renal cell carcinoma - ccRCC) Single cell sequencing identifies intratumoral heterogeneity with distinct mutation patterns but no single dominant clone.
Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferati ve neoplasm. Cell (2012) Single Cell WXS 1 Myeloproliferative Neoplasm (MPN) Single cell sequencing establishes monoclonal origin of an essential thrombocythemia (ET).
The life history of 21 breast cancers. Cell (2012) WGS 21 Breast Cancers, Various Subtypes Typical breast tumors consist of one dominant clone with additional minor subclones sharing a common origin.
The origin and evolution of mutations in acute myeloid leukemia. Cell (2012) WGS 24 AML M1/M3 primary tumors Clonal origins of AML reflect a small number of driver mutations accompanied by of a larger number of random background mutations that accumulate in stem cells over time.
Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature (2010) WGS 1 Breast Cancer (Basal-like – Primary, Metastasis, Xeno graft) Patterns of clonal enrichment and divergence emerge in metastasis and xenograft from a primary tumor.
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481 (2012) WGS 8 Acute myeloid leukemia relapse (AML) Mutational patterns establish clonal expansion and tumor evolution in AML relapse (post chemotherapy)